These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12324790)

  • 1. Frey syndrome--delayed clinical onset: a case report.
    Malatskey S; Rabinovich I; Fradis M; Peled M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Sep; 94(3):338-40. PubMed ID: 12324790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial parotidectomy versus retrograde partial superficial parotidectomy in treating benign salivary gland tumor (pleomorphic adenoma).
    Emodi O; El-Naaj IA; Gordin A; Akrish S; Peled M
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2092-8. PubMed ID: 20728030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Frey Syndrome Rates Following Superficial Parotidectomy and Partial Superficial Parotidectomy for Pleomorphic Adenoma.
    Ogreden S; Ruzgar S; Alimoglu Y; Eroglu S; Taskin U; Oktay MF
    J Craniofac Surg; 2016 Jul; 27(5):e469-71. PubMed ID: 27391515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Alternative Method to Prevent Frey Syndrome After Resection of Huge Masses in Parotis: De-epithelialized Skin Flap Use.
    Yaşar EK; Polat B; Alagöz MŞ
    J Craniofac Surg; 2023 Jul-Aug 01; 34(5):e531-e533. PubMed ID: 37236619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of irradiate animal pericardium membrane for prevention of Frey's syndrome after parotidectomy.
    Gennaro P; Di Curzio P; Mitro V; Facchini A; Saponaro G; Cascino F; Amodeo G; Gabriele G; Ungari C
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):548-51. PubMed ID: 23467957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat injections for the management of post-parotidectomy Frey syndrome: a technical note.
    Torretta S; Pignataro L; Capaccio P; Brevi A; Mazzola R
    J Craniomaxillofac Surg; 2012 Feb; 40(2):173-6. PubMed ID: 21458286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of allogenic acellular dermal matrix in prevention of Frey's syndrome after parotidectomy.
    Ye WM; Zhu HG; Zheng JW; Wang XD; Zhao W; Zhong LP; Zhang ZY
    Br J Oral Maxillofac Surg; 2008 Dec; 46(8):649-52. PubMed ID: 18547692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gustatory sweating: clinical implications and etiologic aspects.
    Laskawi R; Ellies M; Rödel R; Schoenebeck C
    J Oral Maxillofac Surg; 1999 Jun; 57(6):642-8; discussion 648-9. PubMed ID: 10368086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unusually long latency before the appearance of Frey's syndrome after parotidectomy].
    Wenzel GI; Draf W
    HNO; 2004 Jun; 52(6):554-6. PubMed ID: 15257402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of benign tumors of the parotid gland: extracapsular dissection versus superficial parotidectomy--our experience in 232 cases.
    Dell'Aversana Orabona G; Bonavolontà P; Iaconetta G; Forte R; Califano L
    J Oral Maxillofac Surg; 2013 Feb; 71(2):410-3. PubMed ID: 22884114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Parotid Gland Fascia in the Prevention of Frey Syndrome After Parotidectomy.
    Ogino A; Onishi K; Nakamichi M; Okaneya T
    J Craniofac Surg; 2019 Jun; 30(4):1009-1011. PubMed ID: 30882571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial parotidectomy: technical modifications based on tumour characteristics.
    Papadogeorgakis N; Skouteris CA; Mylonas AI; Angelopoulos AP
    J Craniomaxillofac Surg; 2004 Dec; 32(6):350-3. PubMed ID: 15555516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auriculotemporal Syndrome (Frey Syndrome).
    Motz KM; Kim YJ
    Otolaryngol Clin North Am; 2016 Apr; 49(2):501-9. PubMed ID: 26902982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frey's syndrome: prevention with conservative parotidectomy and superficial musculoaponeurotic system preservation.
    Yu LT; Hamilton R
    Ann Plast Surg; 1992 Sep; 29(3):217-22. PubMed ID: 1326250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of predictors for Frey syndrome after parotidectomy].
    Han Y; Wen LT; Tian KY; Chen J; Chen Y; Shi L; Deng ZH; Zha DJ; Qiu JH
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):854-857. PubMed ID: 31446704
    [No Abstract]   [Full Text] [Related]  

  • 16. Partial superficial parotidectomy as the method of choice for treating pleomorphic adenomas of the parotid gland.
    Papadogeorgakis N
    Br J Oral Maxillofac Surg; 2011 Sep; 49(6):447-50. PubMed ID: 20638162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frey's syndrome after parotidectomy: a retrospective and prospective analysis.
    Linder TE; Huber A; Schmid S
    Laryngoscope; 1997 Nov; 107(11 Pt 1):1496-501. PubMed ID: 9369396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Frey syndrome using botulinum neurotoxin: a case report.
    Ng S; Torjek C; Hovan A
    J Can Dent Assoc; 2009 Nov; 75(9):651-4. PubMed ID: 19900355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxoid in the management of gustatory sweating (Frey's syndrome) after superficial parotidectomy.
    Birch JF; Varma SK; Narula AA
    Br J Plast Surg; 1999 Apr; 52(3):230-1. PubMed ID: 10474477
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.